Net profit of Cohance Lifesciences declined 46.50% to Rs 74.08 crore in the quarter ended September 2025 as against Rs 138.47 crore during the previous quarter ended September 2024. Sales declined 7.98% to Rs 555.57 crore in the quarter ended September 2025 as against Rs 603.77 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 555.57 | 603.77 | -8 |
| OPM % | 21.77 | 34.01 | - |
| PBDT | 127.79 | 211.95 | -40 |
| PBT | 83.77 | 174.16 | -52 |
| NP | 74.08 | 138.47 | -47 |